- Fighting the obesity challenge: Lancet study says higher doses of weight loss drugs can safely reduce body weight faster The Indian Express
- Triple Dose Of Novo Nordisk Drug Delivers 19% Weight Loss In Trials-FT TradingView
- Higher dose of Wegovy ups both weight loss and side effects New Scientist
- Drug firm publishes clinical trials tripling Ozempic dose for greater weight loss The Journal
- Triple dose of Novo Nordisk drug delivers 19% weight loss in trials Financial Times
Fighting the obesity challenge: Lancet study says higher doses of weight loss drugs can safely reduce body weight faster The Indian ExpressTriple Dose Of Novo Nordisk Drug Delivers 19% Weight Loss In Trials-FT TradingViewHigher dose of Wegovy ups both weight loss and side effects New ScientistDrug firm publishes clinical trials tripling Ozempic dose for greater weight loss The JournalTriple dose of Novo Nordisk drug delivers 19% weight loss in trials Financial Times by Soban News (international And National News)
